Echinocandins

Download PDF

Recent Publications on Echinocandins:
Correlation of MIC with Outcome for Candida species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints. The CLSI Antifungal Subcommittee followed the M23-A2 "blueprint" to...	27th June, 2008	University of Iowa, Iowa City, IA; University of Texas, Houston, TX;	J Clin Microbiol. 2008 Jun 25;. DOI Direct Link
Combination Polyene-Caspofungin Treatment of Rhino-Orbital-Cerebral Mucormycosis. Background. @nbsp; It has been axiomatic that echinocandins (e.g.,...	19th June, 2008	1Division of Infectious Diseases, Los Angeles Biomedical Research	Clin Infect Dis. 2008 Jun 17;. DOI Direct Link
[Echinocandins in invasive candidiasis.] Invasive fungal infections on the intensive care unit are predominantly...	13th June, 2008	Neurologisches Rehabilitationszentrum, Greifswald,	Med Klin (Munich). 2008 Jun 15;103(6):397-405. DOI Direct Link
New agents to treat life-threatening fungal infections. Fungi can cause life threatening diseases, particularly in patients with...	13th June, 2008	Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth,	Curr Top Med Chem. 2008;8(7):592-402.
Susceptibility testing and molecular classification of Paecilomyces spp. In vitro susceptibility profile of 58 Paecilomyces clinical isolates are...	4th June, 2008	Servicio de Micologia. Centro Nacional de Microbiologia. Instituto de	Antimicrob Agents Chemother. 2008 Jun 2;. DOI Direct Link
→View more research publications.

Echinocandins Clinical Trials:
Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Invasive Candidiasis;   Esophageal Candidiasis;   Oropharyngeal Candidiasis;   Candidemia
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Invasive Candidiasis;   Esophageal Candidiasis;   Oropharyngeal Candidiasis;   Candidemia
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units	Candidiasis Intervention: Drug: Caspofungin
The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)	Candidiasis Intervention: Drug: Anidulafungin, VER002
Caspofungin for the Treatment of Non-Blood Candida Infections
→View more trials.

Echinocandins Patents:
US Patent No.	Title
6491893	Compounds for targeting and imaging infection and inflammation
6696412	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
6706688	Methods for regulating bud-hypha transitions and cAMP levels by the adenylate cyclase-associated protein gene, CAP1
6716631	Evolution of whole cells and organisms by recursive sequence recombination
6719991	Combination of antimicrobial agents and bacterial interference to coat medical devices
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Echinocandins scientists - we have details of around 114 individuals working on Echinocandins .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.